Publication: Natural products of relevance in the management of attention deficit hyperactivity disorder
Loading...
Date
Advisor
Department
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Type
Abstract
AbstractAttention deficit hyperactivity disorder (ADHD) is among the most common neurodevelopmental disorders characterized by motor hyperactivity, attention deficit, distraction, impulsive behavior, and relationship difficulties. It affects children, and thus over the years, there has been growing attention on the use of natural product formulations and their naturally‐occurring bioactive for overcoming the problem of ADHD. Concerning this issue, this review aims to discuss the ADHD treatment potential of natural products/formulations in vitro, in vivo as well as in clinical trials. To gather the most relevant data regarding bioactive compounds with potential therapeutic effects in the management of ADHD, the following databases were searched: PubMed/MedLine, ScienceDirect, and Google Scholar for articles in English. Various medicinal plants and their isolated biomolecules have been evaluated in vitro, in vivo, and in clinical trials for their ability to treat ADHD. Most of the analyzed research results showed an improvement of ADHD signs and symptoms in in vivo models, but the molecular mechanisms of action of the bioactive compounds are unclear and incompletely elucidated. Further studies are needed to determine the bioactive compound responsible for health‐promoting effects in ADHD. In addition, clinical studies should be performed over longer periods with more participants.
Description
Journal or Series
eFood
ISSN
2666-3066
ISBN
Rights
OPEN
Keywords
natural products, Medline, FOS: Political science, FOS: Law, Biochemistry, Food processing and manufacture, Attention deficit hyperactivity disorder, Attention deficit, RA1190-1270, Health Sciences, Pathology, ADHD, Psychology, clinical studies, preclinical studies, Attention-Deficit/Hyperactivity Disorder, Biology, Political science, Pharmacology, Psychiatry, Distraction, Cholinesterase Inhibitors in Neurodegenerative Diseases, TP368-456, Clinical trial, FOS: Psychology, Psychiatry and Mental health, Complementary and alternative medicine, Toxicology. Poisons, pharmacotherapeutic management, Medicine, Herbal Medicine for Mental Health Treatment, Relevance (law), Law, Neuroscience